eViralHepatitis Review

To Treat or Not To Treat

3 min · 20 de oct de 2022
portada del episodio To Treat or Not To Treat

Descripción

Take our post-test [https://elit.dkbmed.com/issues/154/test] to claim CME credits. To listen to our full-length podcast, click here [https://elit.dkbmed.com/issues/155]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de eViralHepatitis Review!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

45 episodios

episode Hepatitis B: Our Current Understanding artwork

Hepatitis B: Our Current Understanding

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That’s the focus of this Special HBV Edition of eViralHepatitis Review. The first part of this program presented an evidence-based expert commentary by eViralHepatitis Review Program Director Dr. Mark Sulkowski — Professor of Medicine at Johns Hopkins and Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. This second part is an interview providing more in-depth discussions between Dr. Sulkowski and three of medicine’s top CHB experts.  Take our post-test [https://elit.dkbmed.com/issues/155/test] to claim CME credits. To read a companion newsletter click here [https://elit.dkbmed.com/issues/154]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

20 de oct de 202241 min